Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 3 | $30,291,232 |
Sells | 43 | $2,646,007 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
20 Feb 2024 16:06 | DCPH | Deciphera Pharmaceuticals Inc | SHERMAN MATTHEW L | EVP & Chief Medical Officer | 16 Feb 2024 | Sale | 2,615 | 15.6177 | 40,840 | D |
20 Feb 2024 16:05 | DCPH | Deciphera Pharmaceuticals Inc | KELLY THOMAS PATRICK | Chief Financial Officer | 16 Feb 2024 | Sale | 3,010 | 15.6177 | 47,009 | D |
20 Feb 2024 16:05 | DCPH | Deciphera Pharmaceuticals Inc | PITMAN JAMA | SVP, Chief Development Officer | 16 Feb 2024 | Sale | 2,267 | 15.6176 | 35,405 | D |
20 Feb 2024 16:05 | DCPH | Deciphera Pharmaceuticals Inc | MARTIN DANIEL C. | Chief Commercial Officer | 16 Feb 2024 | Sale | 2,267 | 15.6176 | 35,405 | D |
18 Jan 2024 16:15 | DCPH | Deciphera Pharmaceuticals Inc | SHERMAN MATTHEW L | EVP & Chief Medical Officer | 16 Jan 2024 | Sale | 2,435 | 14.4697 | 35,234 | D |
18 Jan 2024 16:15 | DCPH | Deciphera Pharmaceuticals Inc | PITMAN JAMA | SVP, Chief Development Officer | 16 Jan 2024 | Sale | 1,624 | 14.4698 | 23,499 | D |
18 Jan 2024 16:15 | DCPH | Deciphera Pharmaceuticals Inc | KELLY THOMAS PATRICK | Chief Financial Officer | 16 Jan 2024 | Sale | 2,435 | 14.4698 | 35,234 | D |
18 Jan 2024 16:15 | DCPH | Deciphera Pharmaceuticals Inc | MARTIN DANIEL C. | Chief Commercial Officer | 16 Jan 2024 | Sale | 1,624 | 14.4697 | 23,499 | D |
14 Dec 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | HOERTER STEVEN L. | President and CEO | 13 Dec 2023 | Sale | 30,664 | 15.3671 | 471,217 | D |
14 Dec 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | KELLY THOMAS PATRICK | Chief Financial Officer | 13 Dec 2023 | Sale | 2,792 | 15.3671 | 42,905 | D |
14 Dec 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | PITMAN JAMA | See Remarks | 13 Dec 2023 | Sale | 1,662 | 15.3671 | 25,540 | D |
14 Dec 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | MARTIN DANIEL C. | Chief Commercial Officer | 13 Dec 2023 | Sale | 1,727 | 15.3671 | 26,539 | D |
14 Dec 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | SHERMAN MATTHEW L | EVP & Chief Medical Officer | 13 Dec 2023 | Sale | 2,792 | 15.3671 | 42,905 | D |
01 Dec 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | MARTIN DANIEL C. | Chief Commercial Officer | 30 Nov 2023 | Sale | 17,801 | 12.5698 | 223,755 | D |
31 Oct 2023 16:11 | DCPH | Deciphera Pharmaceuticals Inc | SHERMAN MATTHEW L | EVP & Chief Medical Officer | 30 Oct 2023 | Sale | 2,360 | 12.0176 | 28,362 | D |
31 Oct 2023 16:10 | DCPH | Deciphera Pharmaceuticals Inc | PITMAN JAMA | See Remarks | 30 Oct 2023 | Sale | 1,407 | 12.0176 | 16,909 | D |
31 Oct 2023 16:10 | DCPH | Deciphera Pharmaceuticals Inc | MARTIN DANIEL C. | Chief Commercial Officer | 30 Oct 2023 | Sale | 1,407 | 12.0176 | 16,909 | D |
31 Oct 2023 16:09 | DCPH | Deciphera Pharmaceuticals Inc | KELLY THOMAS PATRICK | Chief Financial Officer | 30 Oct 2023 | Sale | 2,316 | 12.0176 | 27,833 | D |
31 Oct 2023 16:09 | DCPH | Deciphera Pharmaceuticals Inc | HOERTER STEVEN L. | President and CEO | 30 Oct 2023 | Sale | 21,573 | 12.0176 | 259,256 | D |
04 Oct 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | SHERMAN MATTHEW L | EVP & Chief Medical Officer | 02 Oct 2023 | Sale | 2,942 | 12.68 | 37,305 | D |
21 Jun 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | PITMAN JAMA | See Remarks | 16 Jun 2023 | Sale | 1,238 | 14.4018 | 17,829 | D |
21 Jun 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | SHERMAN MATTHEW L | EVP & Chief Medical Officer | 16 Jun 2023 | Sale | 1,655 | 14.4018 | 23,835 | D |
21 Jun 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | KELLY THOMAS PATRICK | Chief Financial Officer | 16 Jun 2023 | Sale | 1,655 | 14.4018 | 23,835 | D |
21 Jun 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | MARTIN DANIEL C. | Chief Commercial Officer | 16 Jun 2023 | Sale | 1,238 | 14.4018 | 17,829 | D |
21 Jun 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | FLYNN DANIEL LEE | Chief Scientific Officer | 16 Jun 2023 | Sale | 1,655 | 14.4018 | 23,835 | D |
12 Jun 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | FRIEDMAN FRANKLIN STUART | Director | 08 Jun 2023 | Purchase | 10,000 | 13.8828 | 138,828 | D |
12 May 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | WALSH DENNIS LEO | Director | 10 May 2023 | Purchase | 11,000 | 13.856 | 152,416 | D |
23 Mar 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | HOERTER STEVEN L. | President and CEO | 21 Mar 2023 | Sale | 7,500 | 15.5709 | 116,782 | D |
17 Feb 2023 16:14 | DCPH | Deciphera Pharmaceuticals Inc | PITMAN JAMA | See Remarks | 16 Feb 2023 | Sale | 1,159 | 15.099 | 17,500 | D |
17 Feb 2023 16:12 | DCPH | Deciphera Pharmaceuticals Inc | MARTIN DANIEL C. | Chief Commercial Officer | 16 Feb 2023 | Sale | 1,159 | 15.099 | 17,500 | D |
17 Feb 2023 16:09 | DCPH | Deciphera Pharmaceuticals Inc | KELLY THOMAS PATRICK | Chief Financial Officer | 16 Feb 2023 | Sale | 1,370 | 15.099 | 20,686 | D |
17 Feb 2023 16:07 | DCPH | Deciphera Pharmaceuticals Inc | SHERMAN MATTHEW L | EVP & Chief Medical Officer | 16 Feb 2023 | Sale | 971 | 15.099 | 14,661 | D |
17 Feb 2023 16:04 | DCPH | Deciphera Pharmaceuticals Inc | FLYNN DANIEL LEE | Chief Scientific Officer | 16 Feb 2023 | Sale | 1,370 | 15.099 | 20,686 | D |
16 Feb 2023 16:18 | DCPH | Deciphera Pharmaceuticals Inc | HOERTER STEVEN L. | President and CEO | 14 Feb 2023 | Sale | 30,045 | 16 | 480,720 | D |
24 Jan 2023 18:20 | DCPH | Deciphera Pharmaceuticals Inc | BRIGHTSTAR ASSOCIATES LLC | 10% | 24 Jan 2023 | Purchase | 1,666,666 | 18 | 29,999,988 | D |
19 Jan 2023 16:06 | DCPH | Deciphera Pharmaceuticals Inc | FLYNN DANIEL LEE | Chief Scientific Officer | 17 Jan 2023 | Sale | 2,403 | 21.2413 | 51,043 | D |
19 Jan 2023 16:06 | DCPH | Deciphera Pharmaceuticals Inc | PITMAN JAMA | See Remarks | 17 Jan 2023 | Sale | 1,603 | 21.2413 | 34,050 | D |
19 Jan 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | SHERMAN MATTHEW L | EVP & Chief Medical Officer | 17 Jan 2023 | Sale | 2,403 | 21.2413 | 51,043 | D |
19 Jan 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | MARTIN DANIEL C. | Chief Commercial Officer | 17 Jan 2023 | Sale | 1,603 | 21.2413 | 34,050 | D |
19 Jan 2023 16:05 | DCPH | Deciphera Pharmaceuticals Inc | KELLY THOMAS PATRICK | Chief Financial Officer | 17 Jan 2023 | Sale | 2,403 | 21.2413 | 51,043 | D |
05 Oct 2022 16:05 | DCPH | Deciphera Pharmaceuticals Inc | SHERMAN MATTHEW L | EVP & Chief Medical Officer | 03 Oct 2022 | Sale | 2,587 | 18.73 | 48,455 | D |
21 Jun 2022 16:37 | DCPH | Deciphera Pharmaceuticals Inc | SHERMAN MATTHEW L | EVP & Chief Medical Officer | 16 Jun 2022 | Sale | 1,768 | 10.75 | 19,006 | D |
21 Jun 2022 16:36 | DCPH | Deciphera Pharmaceuticals Inc | PITMAN JAMA | See Remarks | 16 Jun 2022 | Sale | 1,298 | 10.75 | 13,954 | D |
21 Jun 2022 16:35 | DCPH | Deciphera Pharmaceuticals Inc | MARTIN DANIEL C. | Chief Commercial Officer | 16 Jun 2022 | Sale | 1,311 | 10.75 | 14,093 | D |
21 Jun 2022 16:35 | DCPH | Deciphera Pharmaceuticals Inc | KELLY THOMAS PATRICK | Chief Financial Officer | 16 Jun 2022 | Sale | 1,768 | 10.75 | 19,006 | D |
21 Jun 2022 16:34 | DCPH | Deciphera Pharmaceuticals Inc | FLYNN DANIEL LEE | Chief Scientific Officer | 16 Jun 2022 | Sale | 1,768 | 10.75 | 19,006 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)